LENSAR INC (LNSR) Stock Fundamental Analysis

USA Nasdaq NASDAQ:LNSR • US52634L1089

12.42 USD
-0.01 (-0.08%)
Last: Feb 11, 2026, 08:00 PM
Fundamental Rating

2

Taking everything into account, LNSR scores 2 out of 10 in our fundamental rating. LNSR was compared to 186 industry peers in the Health Care Equipment & Supplies industry. LNSR may be in some trouble as it scores bad on both profitability and health. LNSR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • LNSR had negative earnings in the past year.
  • LNSR had a negative operating cash flow in the past year.
  • In the past 5 years LNSR always reported negative net income.
  • LNSR had a negative operating cash flow in each of the past 5 years.
LNSR Yearly Net Income VS EBIT VS OCF VS FCFLNSR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -73.39%, LNSR is doing worse than 73.66% of the companies in the same industry.
Industry RankSector Rank
ROA -73.39%
ROE N/A
ROIC N/A
ROA(3y)-34.59%
ROA(5y)-31.65%
ROE(3y)-81.1%
ROE(5y)-61.69%
ROIC(3y)N/A
ROIC(5y)N/A
LNSR Yearly ROA, ROE, ROICLNSR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • LNSR has a Gross Margin (46.15%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of LNSR has grown nicely.
  • The Profit Margin and Operating Margin are not available for LNSR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.25%
GM growth 5Y2.2%
LNSR Yearly Profit, Operating, Gross MarginsLNSR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1

2. Health

2.1 Basic Checks

  • LNSR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LNSR has been increased compared to 1 year ago.
  • The number of shares outstanding for LNSR has been increased compared to 5 years ago.
  • LNSR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LNSR Yearly Shares OutstandingLNSR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
LNSR Yearly Total Debt VS Total AssetsLNSR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • LNSR has an Altman-Z score of -2.42. This is a bad value and indicates that LNSR is not financially healthy and even has some risk of bankruptcy.
  • LNSR has a Altman-Z score of -2.42. This is in the lower half of the industry: LNSR underperforms 60.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.42
ROIC/WACCN/A
WACC9.82%
LNSR Yearly LT Debt VS Equity VS FCFLNSR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.24 indicates that LNSR should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.24, LNSR is doing worse than 80.11% of the companies in the same industry.
  • LNSR has a Quick Ratio of 1.24. This is a bad value and indicates that LNSR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • LNSR's Quick ratio of 0.67 is on the low side compared to the rest of the industry. LNSR is outperformed by 87.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.67
LNSR Yearly Current Assets VS Current LiabilitesLNSR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. Growth

3.1 Past

  • LNSR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.68%.
  • The Revenue has grown by 21.02% in the past year. This is a very strong growth!
  • LNSR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.87% yearly.
EPS 1Y (TTM)-200.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.46%
Revenue 1Y (TTM)21.02%
Revenue growth 3Y15.79%
Revenue growth 5Y11.87%
Sales Q2Q%5.74%

3.2 Future

  • LNSR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.14% yearly.
  • Based on estimates for the next years, LNSR will show a very strong growth in Revenue. The Revenue will grow by 29.01% on average per year.
EPS Next Y-5.37%
EPS Next 2Y41.42%
EPS Next 3Y29.14%
EPS Next 5YN/A
Revenue Next Year21.28%
Revenue Next 2Y28.37%
Revenue Next 3Y29.01%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LNSR Yearly Revenue VS EstimatesLNSR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
LNSR Yearly EPS VS EstimatesLNSR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2027 0 -2 -4 -6 -8

1

4. Valuation

4.1 Price/Earnings Ratio

  • LNSR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LNSR Price Earnings VS Forward Price EarningsLNSR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LNSR Per share dataLNSR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LNSR's earnings are expected to grow with 29.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y29.14%

0

5. Dividend

5.1 Amount

  • LNSR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LENSAR INC

NASDAQ:LNSR (2/11/2026, 8:00:00 PM)

12.42

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners49.71%
Inst Owner Change-0.6%
Ins Owners19.38%
Ins Owner Change-0.15%
Market Cap148.29M
Revenue(TTM)59.14M
Net Income(TTM)-51.52M
Analysts45.71
Price Target15.3 (23.19%)
Short Float %7.87%
Short Ratio18.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-301.96%
Min EPS beat(2)-507.84%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-687.06%
Min EPS beat(4)-1367.43%
Max EPS beat(4)-96.08%
EPS beat(8)2
Avg EPS beat(8)-359.42%
EPS beat(12)4
Avg EPS beat(12)-250.66%
EPS beat(16)8
Avg EPS beat(16)-183.01%
Revenue beat(2)0
Avg Revenue beat(2)-18.62%
Min Revenue beat(2)-19.8%
Max Revenue beat(2)-17.45%
Revenue beat(4)2
Avg Revenue beat(4)-5.89%
Min Revenue beat(4)-19.8%
Max Revenue beat(4)10.09%
Revenue beat(8)4
Avg Revenue beat(8)-1.11%
Revenue beat(12)6
Avg Revenue beat(12)-0.65%
Revenue beat(16)8
Avg Revenue beat(16)0.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-940.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.51
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.39
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.99
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS4.95
BVpS-1.02
TBVpS-1.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.15%
FCFM N/A
ROA(3y)-34.59%
ROA(5y)-31.65%
ROE(3y)-81.1%
ROE(5y)-61.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.25%
GM growth 5Y2.2%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.94%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.67
Altman-Z -2.42
F-Score3
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)4.73%
Cap/Depr(5y)8.26%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.46%
EPS Next Y-5.37%
EPS Next 2Y41.42%
EPS Next 3Y29.14%
EPS Next 5YN/A
Revenue 1Y (TTM)21.02%
Revenue growth 3Y15.79%
Revenue growth 5Y11.87%
Sales Q2Q%5.74%
Revenue Next Year21.28%
Revenue Next 2Y28.37%
Revenue Next 3Y29.01%
Revenue Next 5YN/A
EBIT growth 1Y-143.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.09%
EBIT Next 3Y40.8%
EBIT Next 5YN/A
FCF growth 1Y16.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.41%
OCF growth 3YN/A
OCF growth 5YN/A

LENSAR INC / LNSR FAQ

What is the ChartMill fundamental rating of LENSAR INC (LNSR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LNSR.


Can you provide the valuation status for LENSAR INC?

ChartMill assigns a valuation rating of 1 / 10 to LENSAR INC (LNSR). This can be considered as Overvalued.


How profitable is LENSAR INC (LNSR) stock?

LENSAR INC (LNSR) has a profitability rating of 1 / 10.


What is the expected EPS growth for LENSAR INC (LNSR) stock?

The Earnings per Share (EPS) of LENSAR INC (LNSR) is expected to decline by -5.37% in the next year.